News

Corvus Pharmaceuticals to Showcase Innovations at Investment Event

Corvus Pharmaceuticals to Showcase Innovations at Investment Event

Corvus Pharmaceuticals to Present at Major Investment Conference

BURLINGAME, Calif. — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a prominent name in the clinical-stage biopharmaceutical sector, is thrilled to announce that its president and CEO, Richard A. Miller, M.D., along with Jeffrey Arcara, the chief business officer, will be participating in one-on-one meetings with investors and delivering a detailed corporate presentation. This important event is set to occur at the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9 to 11, 2024.

Details of the Event and Presentation Highlights

The key highlight of the event will be Corvus Pharmaceuticals' presentation, which is scheduled for Tuesday, September 10 at 12:00 PM ET. Investors and stakeholders will have the chance to gain valuable insights into the company’s strategic vision and its innovative therapies.

Webcast Information

For those who cannot attend in person, a live webcast of the presentation will be available. Moreover, it will remain accessible for 90 days after the conference, allowing interested individuals to catch up on the discussions and insights shared during the event.

About Corvus Pharmaceuticals

Corvus Pharmaceuticals is committed to leading the way in the development of ITK (Interleukin-2-inducible T-cell kinase) inhibition, paving a new path in immunotherapy for various cancers and immune-related conditions. The company’s lead candidate, soquelitinib, is an oral, investigational small molecule drug designed to selectively inhibit ITK. This groundbreaking innovation has the potential to transform treatment approaches for some significant health challenges.

Current Clinical Developments

In addition to soquelitinib, Corvus Pharmaceuticals is actively working on a portfolio of other clinical-stage candidates aimed at addressing different types of cancer. Their dedication to meeting unmet needs in the therapeutic landscape highlights their role as a leader in pioneering treatments.

Investor and Media Contact Information

INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
Phone: +1-650-900-4522
Email: llea@corvuspharma.com

MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
Phone: +1-949-903-4750
Email: sseapy@realchemistry.com

Frequently Asked Questions

1. Why is the H.C. Wainwright conference important for Corvus Pharmaceuticals?

The conference serves as a crucial opportunity for Corvus to engage with investors and provide updates on their innovative therapeutic strategies in oncology.

2. Who will represent Corvus Pharmaceuticals at the conference?

Richard A. Miller, M.D., the president and CEO, along with Jeffrey Arcara, Chief Business Officer, will be representing the company.

3. What can attendees expect from the conference presentation?

The presentation is designed to offer insights into the company's strategies, product pipeline, and future directions in cancer treatment.

4. How can individuals access the presentation if they are unable to attend?

A live webcast of the presentation will be available on the Corvus website, and a recording will be accessible for 90 days after the event.

5. What is the primary focus of Corvus Pharmaceuticals?

Corvus is focused on developing innovative therapies that target ITK inhibition to address a wide range of cancer and immune diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 1

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
ASCEND® Cladding Unveils New Profiles & Texture Variety

Updated Category News Views 0

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Continue Reading
WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Updated Category News Views 4

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Continue Reading
How Timekettle Is Bridging Language Gaps at IFA 2026

Updated Category News Views 1

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 6

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 1

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
Nashville Benefit Concert Supports Animal Rescue Mission

Updated Category News Views 1

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices

Updated Category News Views 2

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 1

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading

Top 5 Most Recently Viewed Articles

Mowery & Schoenfeld Wealth Awarded Top Advisory Firm by Newsweek

Updated Category News Views 101

Mowery & Schoenfeld Wealth Celebrated as One of America’s Elite Financial Advisory Firms Mowery & Schoenfeld Wealth is thrilled to share the remarkable news of being listed among America’s Top Financial Advisory Firms for 2025 by Newsweek. This honor reflects the firm’s continuous pursuit of excellence in providing personalized financial guidance, groundbreaking...

Continue Reading
Luminar Technologies Reaches New Heights Amid Market Shifts

Updated Category News Views 221

Luminar Technologies Achieves 52-Week High In a market characterized by fluctuations and uncertainty, Luminar Technologies Inc. (NASDAQ: LAZR) has recently announced a significant achievement, touching a 52-week high of $11.39. This milestone is particularly noteworthy for a company that specializes in cutting-edge lidar sensors crucial for the operation of autonomous...

Continue Reading
AKWEL Reports Declining Revenue Over Nine-Month Period

Updated Category News Views 35

AKWEL's Revenue Decline Overview AKWEL, a distinguished manufacturer in the automotive and heavy-vehicle sectors, has recently reported its financial performance for the first nine months of the fiscal year, revealing a notable 5.2% decrease in consolidated revenue compared to the previous period. By the end of September, their revenue totaled €757.7 million, as the...

Continue Reading
Truist Securities Boosts O'Reilly Automotive Target to $1,313

Updated Category News Views 214

Truist Raises Price Target for O'Reilly Automotive Recently, Truist Securities made a notable update on O'Reilly Automotive (NASDAQ: ORLY), revising its price target from $1,290 to an impressive $1,313. This decision, backed by a Buy rating, comes on the heels of the company's robust performance in the third quarter, showing resilience despite the broader challenges faced...

Continue Reading
CGA Expands Team with Cybersecurity Experts for Impactful Insights

Updated Category News Views 304

CGA Expands Team with Cybersecurity Experts In a world where uncertainties loom large, organizations, both public and private, are in constant search of trusted partnerships that can provide clarity on government cyber policy and operations. Cambridge Global Advisors (CGA), a respected service-disabled veteran-owned small business specializing in homeland and national...

Continue Reading